Direct Therapeutics, Inc. is a development-stage pharmaceutical company using its patented Solvent-Facilitated Perfusion technology to create new drugs for the localized and regional treatment of solid-tumor cancers. Our products are designed for direct injection to target tissue with minimal invasion of healthy tissue. They contain active ingredients in organic solvent vehicles that facilitate the penetration of the drug throughout tumor tissue and into tumor cells. In contrast to “sustained release” or “controlled release” products, our products rapidly, selectively, and thoroughly saturate tumors with doses of potent chemotherapeutic agents unachievable by other means. We have demonstrated that these products, when directly applied by needle or catheter to solid tumors, perfuse preferentially throughout the tumor, leading to rapid, selective death of cancerous tissue.
Sagent Pharmaceuticals: SAGENT Pharmaceuticals is an innovative company based upon a unique business model that allows us to… See Company Profile »
Image Credit: Flickr/ brendanlimSix months ago, 23andMe chief legal officer and general counsel Ashley Gould left the company. This departure may… Continue reading 〉
We talk a lot about customer development, but there’s nothing like seeing it in action to understand its power. Here’s… Continue reading 〉
SPONSORED POSTCheck out our press release hub, powered by Business Wire. It's a one stop shop for industry announcements to help you stay on… Continue reading 〉